Pnc Financial Services Group, Inc. Pro Qr Therapeutics N.V. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 28,903 shares of PRQR stock, worth $74,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,903Holding current value
$74,858% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
82Shares Held
45.1MCall Options Held
31.4KPut Options Held
24.7K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.6MShares$24.9 Million0.05% of portfolio
-
Privium Fund Management B.V.4.99MShares$12.9 Million3.12% of portfolio
-
Woodline Partners LP San Francisco, CA3.56MShares$9.21 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$7.32 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.83MShares$7.32 Million1.38% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $185M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...